Stockscreener 앱 받기
0.436
3.33%
-0.015
시간 외 거래:
.42
-0.016
-3.67%
전일 마감가:
$0.451
열려 있는:
$0.4473
하루 거래량:
65,144
Relative Volume:
0.16
시가총액:
$11.11M
수익:
$56.04M
순이익/손실:
$-20.39M
주가수익비율:
-0.1787
EPS:
-2.44
순현금흐름:
$-6.84M
1주 성능:
-12.97%
1개월 성능:
-20.39%
6개월 성능:
-50.23%
1년 성능:
-38.59%
1일 변동 폭
$0.4012
$0.4477
1주일 범위
$0.35
$0.51
52주 변동 폭
$0.35
$1.58
Cosmos Health Inc Stock (COSM) Company Profile
명칭
Cosmos Health Inc
전화
312-536-3102
주소
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
COSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.436 | 11.11M | 56.04M | -20.39M | -6.84M | -2.44 |
|
MCK
Mckesson Corporation
|
672.99 | 84.39B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
278.09 | 53.07B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
137.77 | 33.65B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
68.49 | 8.54B | 12.50B | 314.00M | 421.00M | 2.44 |
|
PDCO
Patterson Companies Inc
|
31.24 | 2.75B | 6.55B | 155.22M | -823.13M | 1.71 |
Cosmos Health Inc 주식(COSM)의 최신 뉴스
Cosmos Holdings stock hits 52-week low at $0.44 - Investing.com India
Cosmos Health CEO acquires $44,999 in stock through debt exchange By Investing.com - Investing.com South Africa
Cosmos Health CEO acquires $44,999 in stock through debt exchange - Investing.com
Cosmos Holdings stock hits 52-week low at $0.46 - Investing.com India
Cosmos health CEO acquires shares worth $65,000 in debt exchange By Investing.com - Investing.com South Africa
Cosmos health CEO acquires shares worth $65,000 in debt exchange - Investing.com
Cosmos Health CEO Acquires Over 130K Shares Through Debt Exchange - TradingView
Cosmos Health Inc. (NASDAQ:COSM) Might Not Be As Mispriced As It Looks After Plunging 31% - simplywall.st
Cosmos Holdings stock hits 52-week low at $0.46 By Investing.com - Investing.com Canada
Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company - ACCESS Newswire
Cosmos Health expands distribution of Avian Influenza kits - MSN
Cosmos Holdings Inc. Changes its Name to Cosmos Health Inc. and Announces a 1-For-25 Reverse Stock Split - ACCESS Newswire
Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates - ACCESS Newswire
Cosmos Health CEO Grigorios Siokas acquires $200,000 in stock By Investing.com - Investing.com Canada
Cosmos Health CEO Grigorios Siokas acquires $200,000 in stock - Investing.com India
Cosmos Health CEO Acquires Shares Through Debt Exchange Agreement - TradingView
Tuesday 2/25 Insider Buying Report: COSM, SEPN - Nasdaq
Bullish Cosmos Health Insiders Loaded Up On US$539.0k Of Stock - Yahoo Finance
Cosmos Health postpones securities offering By Investing.com - Investing.com South Africa
Cosmos Health postpones securities offering - Investing.com India
Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1 - ACCESS Newswire
Strategic Shift: Cosmos Health Postpones Capital Raise, Prioritizes Annual Report - StockTitan
Cosmos Health Inc. (NASDAQ:COSM) Short Interest Down 39.7% in January - Defense World
Cosmos Health advances weight management device to clinical trials - MSN
Cosmos health CEO Grigorios Siokas acquires shares worth $29,999 - MSN
Cosmos Health Inc. (COSM) Expands IP Portfolio with AI-Driven Drug Repurposing Patents - Yahoo Finance
Cosmos Health files patents for cancer treatments By Investing.com - Investing.com Australia
Cosmos Health advances weight management device to clinical trials By Investing.com - Investing.com South Africa
Cosmos Health Enters Final Development Phase of CCX0722 Weight M - WICZ
Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market - ACCESS Newswire
Cosmos Health's Novel Weight Loss Device Enters Clinical Phase, Eyes Massive $142B Market Opportunity - StockTitan
Cosmos Health files patents for cancer treatments - Investing.com India
Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market - ACCESS Newswire
AI Breakthrough: Cosmos Health's Dual Cancer Patents Could Revolutionize $25B Treatment Market - StockTitan
Cosmos Health Appoints Dimitris Moraitis as Vice President of Strategy & Operations - citybiz
Cosmos Health Strengthens Management Team with the Appointment o - WICZ
Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations - ACCESS Newswire
Analyzing Ratios: Cosmos Health Inc (COSM)’s Financial Story Unveiled - The Dwinnex
Cosmos Health secures a 10-year contract with Provident - MSN
Cosmos Health Requests Appeal from the Nasdaq Stock Market - ACCESS Newswire
Cosmos Health Inc (NASDAQ: COSM) Up 32.86% From 52-Week Low; YTD Jumps 4.63% – Here’s What To Do Now - Marketing Sentinel
Cosmos Health secures a 10-year contract with Provident By Investing.com - Investing.com South Africa
Cosmos Health Inc (COSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
18.97%
5.24%
자본화:
|
볼륨(24시간):